Related Experiment Video
Updated: Dec 27, 2025
11:30
A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
2.2K
Vascular and valvular calcification biomarkers.
Alberto Clemente1, Irene Traghella1, Annamaria Mazzone1
1Fondazione CNR-Regione Toscana G. Monasterio, Pisa, Italy.
Advances in Clinical Chemistry
|March 4, 2020
Summary
Vascular and valvular calcification are serious health issues. Understanding distinct pathophysiological mechanisms and emerging biological markers like Fetuin A is crucial for improved diagnosis and personalized treatment strategies.
Area of Science:
- Cardiovascular Medicine
- Clinical Chemistry
- Biomarkers
Background:
- Vascular and valvular calcification pose significant clinical challenges.
- Understanding the distinct pathophysiological mechanisms is key for targeted therapies.
- Medical laboratorians require updated knowledge on diagnostic and management tools.
Purpose of the Study:
- To review the pathophysiology of vascular and valvular calcification.
- To discuss current and emerging diagnostic markers and tools.
- To highlight the role of laboratory medicine in precision medicine for calcification.
Main Methods:
- Literature review focusing on pathophysiology, biomarkers, and assessment tools.
- Discussion of established and novel biological markers (e.g., Fetuin A, Matrix Gla Protein).
- Exploration of functional assays and omic technologies for calcification assessment.
Main Results:
- Distinct pathophysiological pathways exist for vascular versus valvular calcification.
- Fetuin A and Matrix Gla Protein are key biological markers.
- Functional assays show promise for vascular calcification assessment.
Conclusions:
- Differentiated healthcare approaches are needed for vascular and valvular calcification.
- Emerging biomarkers and technologies will advance diagnosis and management.
- Laboratory medicine plays a vital role in precision medicine for calcification-related diseases.
Related Concept Videos
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
309
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
309
01:20Imaging Studies for Cardiovascular System III: X-Ray
422
The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
422
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
472
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
472
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
707
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
707
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
231
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
231